Latest News Releases

September 28, 2016
A safe and effective vaccine to protect against Zika virus infection is essential and should be feasible to develop, according to a commentary in the September 29th print issue of The New England Journal of Medicine by Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH); Hilary D. Marston, M.D., of NIAID; Nicole Lurie, M.D., M.S.P.H., Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services; and Luciana L. Borio, M.D., acting chief scientist, U.S. Food and Drug Administration. The federal officials describe three potential strategies for conducting Zika vaccine clinical trials with each strategy dependent on disease incidence and likelihood of generating reliable data.

NIAID-Funded Research News

Submit a Media Request

Contact the NIAID Media Team.

All Media Contacts

NIAID Images & Video